Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice
Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice
← All Articles
Drug Prices

Vraylar Price by Country: $1,595 in the US, about $115 in the UK

Europe sells cariprazine as Reagila. Here is what 30 days of one capsule a day cost in seven places — every strength costs about the same.

November 2026 · Updated November 9, 2026 · By Wellness Vision 5 min read 17 sources

Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →

Key Takeaways

  • The US list price rose 16% in two years. AbbVie lists Vraylar at $1,594.82 for a 30-day supply as of January 2026; CMS recorded $1,376 for 2024 (our calculation: $1,594.82 ÷ $1,376). US pharmacies’ cost per capsule rose 5% on January 2, 2026 (CMS NADAC).
  • $770 for Medicare from 2027. Medicare’s negotiated price for a 30-day supply takes effect on January 1, 2027 — 44% below the 2024 list price, according to CMS. Per capsule it is $26.99 for every strength, or $810 for 30 capsules (our calculation).
  • Europe: about $92 to $147 for 30 days. Official prices for Reagila, scaled from packs of 28 to 30 capsules and converted at ECB rates: Austria $92, the Netherlands $106, the UK $115, Switzerland $147 (our calculation).
  • Germany: a benefit verdict, but no price ceiling. Germany’s Joint Federal Committee found no proven added benefit for acute schizophrenia, and a hint of minor added benefit only for long-term treatment with mainly negative symptoms (2018). Cariprazine has no Festbetrag, and France does not list it.

Vraylar / Reagila Price by Country (November 2026)

Vraylar (cariprazine; sold in Europe as Reagila) is one capsule once a day — 1.5 to 6 mg for schizophrenia, lower maximums for depression (FDA label) — so 30 days = 30 capsules. In the US, the UK, Switzerland and Austria every strength costs the same per pack; in the Netherlands the 3, 4.5 and 6 mg capsules cost more than 1.5 mg, and we show 3 mg. European packs hold 28 capsules; we scale to 30 (our calculation: pack price ÷ 28 × 30). US dollars at European Central Bank reference rates of November 6, 2026. The price types differ — list price, negotiated price, pharmacy acquisition cost, retail price — and are labelled.

30 days = 30 capsules. US: AbbVie list price (January 2026), CMS data file ($26.986339 per capsule from 2027 × 30, our calculation), CMS NADAC for 3 mg (as of November 4, 2026). UK: NHS dm+d. Switzerland: BAG public price. Austria: Erstattungskodex, November 2026 (excl. VAT). Netherlands: Zorginstituut average price for 3 mg (to November 1, 2026). Packs of 28 scaled to 30 capsules and converted at ECB rates of November 6, 2026 (our calculation).
CountryOfficial price30 days in US dollarsWhat a patient typically pays
🇺🇸 United States (list)$1,594.82 for a 30-day supply (AbbVie, as of Jan 2026)$1,595Commercially insured patients may pay as little as $0 with the maker’s savings card (maker’s statement)
🇺🇸 United States (pharmacy cost)$50.86166 per 3 mg capsule (CMS NADAC, Nov 4, 2026)$1,526—
🇺🇸 United States (Medicare, 2027)$770 negotiated price per 30-day supply, from Jan 1, 2027 (CMS); $26.986339 per capsule$810Depends on the Part D plan and coverage phase
🇬🇧 United KingdomReagila £80.36 for 28 capsules, every strength (NHS price, since Sep 28, 2018)$115£9.90 per item in England; free in Scotland, Wales and Northern Ireland
🇨🇭 SwitzerlandReagila CHF 112.65 for 28 capsules, every strength (public price)$14710% share after the annual deductible
🇦🇹 AustriaReagila €76.75 for 28 capsules (social-insurance price excl. VAT; effective price may be lower under a price model)$92€7.55 prescription fee per pack; freely prescribable
🇳🇱 NetherlandsReagila 3 mg €88.20 for 28 capsules; 1.5 mg €72.56 (average pharmacy price)$106Fully reimbursed; counts toward the annual deductible
🇫🇷 FranceNo cariprazine product in the public medicines database——
🇩🇪 GermanyNo statutory price ceiling (Festbetrag) for cariprazine; no official price found——

We compare prices; we do not recommend where to buy medicine. Never stop or switch an antipsychotic without your doctor.

What the Numbers Mean

Why the US price went up, not down

AbbVie’s list price of $1,594.82 (January 2026) is about 16% above the $1,376 that CMS recorded for 2024 (our calculation). NADAC for a 3 mg capsule was $48.52951 from December 17, 2025 and $50.95598 from January 2, 2026 — a rise of 5% (our calculation). The negotiated Medicare price of $770 takes effect on January 1, 2027; in 2024 about 118,000 people with Medicare Part D used Vraylar, and Part D spent $1.14 billion on it before rebates (CMS).

Europe: 6% to 9% of the US list price

Austria, the Netherlands, the UK and Switzerland publish an official price for Reagila — about $92 to $147 for 30 capsules at ECB rates, or 6% to 9% of the US list price (our calculation: $92 ÷ $1,595 and $147 ÷ $1,595). Medicare’s 2027 price is still more than five times the Swiss price (our calculation: $810 ÷ $147).

Germany: what the benefit assessment found

In 2018 the Joint Federal Committee (G-BA) found no proven added benefit for acute treatment of schizophrenia or long-term treatment without predominant negative symptoms, and a hint of a minor added benefit over risperidone for long-term treatment with predominantly negative symptoms. Cariprazine has no Festbetrag, and we found no freely published official German price.

Frequently Asked Questions

How much does Vraylar cost in the US compared with other countries?

AbbVie lists Vraylar at $1,594.82 for a 30-day supply (as of January 2026), and US pharmacies paid about $1,526 for 30 capsules of 3 mg in November 2026 (CMS NADAC). Medicare’s negotiated price from January 1, 2027 is $770 for a 30-day supply (CMS). In Europe, cariprazine is sold as Reagila: £80.36 for 28 capsules in the UK, €76.75 in Austria (excl. VAT), €88.20 in the Netherlands and CHF 112.65 in Switzerland — about $92 to $147 for 30 days at ECB rates.

Is Reagila the same as Vraylar?

Both contain cariprazine. In the EU, Reagila is authorised for schizophrenia in 1.5, 3, 4.5 and 6 mg capsules (EMA); in the US, Vraylar is also approved for bipolar I disorder and major depressive disorder (FDA label).

Does a higher dose cost more?

Not in the US, the UK, Switzerland or Austria: every strength costs the same per capsule or per pack there (CMS data file, NADAC, dm+d, BAG, Erstattungskodex). In the Netherlands 3, 4.5 and 6 mg cost €88.20 for 28 capsules and 1.5 mg €72.56.

What do patients pay?

AbbVie says commercially insured patients may pay as little as $0 with its savings card. In England each prescription item costs £9.90; in Switzerland insured patients pay a 10% share after the deductible; in Austria a €7.55 prescription fee; in the Netherlands it is fully reimbursed but counts toward the annual deductible.

Is there a generic Vraylar?

Not that we found: CMS negotiates only drugs without generic competition, the US pharmacy price survey (NADAC, November 4, 2026) lists only Vraylar, and the Dutch price list shows no generic cariprazine.

Sources

  1. AbbVie — Vraylar cost and savings: "The list price, also known as the wholesale acquisition cost (WAC), for a 30-day supply of VRAYLAR is $1,594.82 as of January 2026"; savings card as little as $0
  2. CMS — Negotiated prices for initial price applicability year 2027 (fact sheet, November 2025): Vraylar $770 negotiated price for a 30-day supply, $1,376 list price (2024), 44% lower; 118,000 Part D enrollees, $1,136,814,000 gross Part D costs in 2024
  3. CMS — Selected drug list and maximum fair price data file (November 2, 2026): Vraylar $26.986339 per capsule (all strengths) from January 1, 2027
  4. CMS — Medicare Drug Price Negotiation Program: final guidance and effectuation of the negotiated price
  5. CMS — NADAC, as of November 4, 2026: Vraylar 3 mg $50.86166 per capsule (effective October 21, 2026); $48.52951 effective December 17, 2025, $50.95598 effective January 2, 2026
  6. DailyMed — Vraylar prescribing information: once daily; schizophrenia 1.5 to 6 mg
  7. NHS dm+d — Reagila 3 mg capsules, 28: NHS indicative price £80.36 (since September 28, 2018; same for 1.5, 4.5 and 6 mg)
  8. NHS Business Services Authority — prescription charge £9.90 per item (England)
  9. European Medicines Agency — Reagila product information: 1.5, 3, 4.5 and 6 mg capsules for schizophrenia; EU/1/17/1209/003 and /013 = 28 capsules
  10. Federal Office of Public Health (BAG) — Spezialitätenliste: Reagila 1.5 to 6 mg, 28 capsules, public price CHF 112.65; cost share 10%
  11. Austrian social insurance (Dachverband) — Erstattungskodex monthly data, November 2026: Reagila 1.5 to 6 mg, 28 capsules, €76.75 (social-insurance price excl. VAT; green box; price model)
  12. oesterreich.gv.at — prescription fee (Rezeptgebühr) €7.55 per pack since January 1, 2026
  13. Zorginstituut Nederland — Medicijnkosten.nl: Reagila 3 mg (EU/1/17/1209/013), average price €88.20 per pack; 1.5 mg €72.56; fully reimbursed (updated to November 1, 2026)
  14. Gemeinsamer Bundesausschuss — benefit assessment of cariprazine, decision of October 4, 2018
  15. Base de données publique des médicaments (France) — no cariprazine product listed (bulk files of November 6, 2026)
  16. BfArM / GKV-Spitzenverband — Festbetrag list as of November 1, 2026 (no entry for cariprazine)
  17. European Central Bank — reference rates, November 6, 2026 (1 US dollar = €0.89566 = £0.74711 = CHF 0.8189)

Related Cost Comparisons

Wellness Vision Editorial Policy

Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; currency conversions and 30-day figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.

You shouldn't have to go broke to feel whole.